FDA Approved: DOXAZOSIN — Supplemental Application (Apotex Corp.)

View source ↗

Summary

FDA approved Apotex Corp.'s supplemental application for doxazosin, a generic alpha-1 blocker used to treat hypertension and benign prostatic hyperplasia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Prostatic Hyperplasia
• Hypertension

Drugs mentioned

• Doxazosin (doxazosin)

Snippet

SUPPL AP for DOXAZOSIN (DOXAZOSIN)